Cargando…
Intravenous treprostinil via an implantable pump in pediatric pulmonary arterial hypertension
Intravenous prostacyclin-based therapy improves survival in children with pulmonary arterial hypertension (PAH), but is typically administered via an external infusion pump, which places a considerable burden on the patient. Implanted pumps may overcome some of the limitations of external pumps. We...
Autores principales: | Desole, Susanna, Richter, Manuel Jonas, Heine, Alexander, Ewert, Ralf |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6295941/ https://www.ncbi.nlm.nih.gov/pubmed/29944075 http://dx.doi.org/10.1177/2045894018788846 |
Ejemplares similares
-
Flow rate variance of a fully implantable pump for the delivery of intravenous treprostinil in pulmonary arterial hypertension
por: Richter, Manuel J., et al.
Publicado: (2020) -
An implantable pump Lenus pro® in the treatment of pulmonary arterial hypertension with intravenous treprostinil
por: Kurzyna, Marcin, et al.
Publicado: (2017) -
Periprocedural safety and outcome after pump implantation for intravenous treprostinil administration in patients with pulmonary arterial hypertension
por: Kamp, Jan C., et al.
Publicado: (2021) -
Long-term experience with implantable infusion pumps for intravenous
treprostinil in pulmonary arterial hypertension—procedural safety and system-related
complications
por: Steringer-Mascherbauer, Regina, et al.
Publicado: (2020) -
Inhaled treprostinil and pulmonary arterial hypertension
por: Nadler, Samuel T, et al.
Publicado: (2010)